Amesite Seeks Approval for 1-for-250 Reverse Split and $25M Discounted Offering
AMST sits 22% above its 52-week low of $0.77 on light trading volume (0.3× avg).
Summary
Amesite's preliminary proxy seeks shareholder approval for a reverse stock split up to 1-for-250 and up to $25M in discounted non-public offerings, both aimed at shoring up its Nasdaq listing and cash position.
Key Events · Corporate Governance and Compliance · AMST
-
Reverse Split Up to 1-for-250
Proposal 3 authorizes the Board to effect a reverse stock split at a ratio between 1-for-2 and 1-for-250, at its discretion, within one year of approval. The stated purpose is to regain compliance with Nasdaq's minimum bid price requirement.
-
$25M Discounted Offering Authorization
Proposal 4 seeks approval under Nasdaq Rule 5635(d) to issue securities in non-public offerings exceeding 19.99% of outstanding shares at less than the Nasdaq minimum price, for aggregate proceeds up to $25 million, with discounts of up to 80% to market.
-
Severe Dilution Risk
The offering authorization could result in issuance of shares far exceeding the current 6.55M outstanding, at prices potentially as low as $0.19 per share (80% discount to $0.94). The filing states the level of dilution cannot be determined at this time.
-
Going Concern Backdrop
The proxy follows the September 23 10-K which disclosed a going concern warning, a $3.1M annual loss, and only $2.4M in cash — roughly one year of runway. These proposals are survival measures.
Analysis · AMST · Technology
At its December 10 annual meeting, Amesite is asking shareholders to approve two aggressive capital-raising tools: a reverse stock split of up to 1-for-250 and authorization to sell up to $25 million in discounted non-public offerings. The reverse split is aimed at regaining Nasdaq compliance, while the offering authorization would allow the company to issue shares at up to an 80% discount to market. Against a backdrop of a going-concern warning, a $3.1M annual loss, and only $2.4M in cash, these proposals signal that management is preparing for significant dilution to extend its runway.
How filings like this one have moved
In the 30 days to Oct 2, 2026, 36.5% of the 1055 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.56%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, AMST was trading at $0.94 on NASDAQ in the Technology sector, with a market capitalization of approximately $6.2M. The 52-week trading range was $0.77 to $3.90. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.